Co-morbidity except essential arterial hypertension controlled by treatment, stable coronary disease, type 2 diabetes and/or degenerative arthropathy (non-inflammatory rheumatic disorder)

Acute disorder during 8 weeks before inclusion, especially COPD worsening

Long-term corticosteroid or non-steroid anti-inflammatory treatment

Role of Systemic Inflammation in Increase of Cardio-vascular Risk in Chronic Obstructive Pulmonary Disease

What this study is about